Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: Results of a prospective study

Colorectal Disease

Volumn 13, Issue 11, 2011, Pages

  Peng, J ^a,b   He, Y ^a,b   Xu, J ^a,b   Sheng, J ^a,b   Cai, S ^a,b   Zhang, Z ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

18F FDG; Colorectal cancer; PET CT; SUVmax

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BENIGN TUMOR; COLON BIOPSY; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; HUMAN; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM BIOPSY;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; LYMPHOMA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80054051756     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02727.x     Document Type: Article

References (22)

1. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000; 30: 150-85.
2. Kluetz PG, Meltzer CC, Villemagne VL et al. Combined PET/CT Imaging in Oncology. Impact on patient management. Clin Positron Imaging 2000; 3: 223-30.
3. Rehani B, Chasen RM, Dowdy Y et al. Advanced adenoma diagnosis with FDG PET in a visibly normal mucosa: a case report. J Med Case Reports 2007; 1: 99.
4. Agrawal A, Nair N, Agrawal R, Baghel NS. Unsuspected second malignancy detection by FDG PET scan. Clin Nucl Med 2008; 33: 868-9.
5. Gutman F, Alberini JL, Wartski M et al. Incidental colonic focal lesions detected by FDG PET/CT. AJR Am J Roentgenol 2005; 185: 495-500.
6. Weston BR, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer 2010; 116: 1454-61.
7. Kamel EM, Thumshirn M, Truninger K et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med 2004; 45: 1804-10.
8. Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 2002; 224: 783-7.
9. Friedland S, Soetikno R, Carlisle M, Taur A, Kaltenbach T, Segall G. 18-Fluorodeoxyglucose positron emission tomography has limited sensitivity for colonic adenoma and early stage colon cancer. Gastrointest Endosc 2005; 61: 395-400.
10. Ravizza D, Bartolomei M, Santoro L et al. Positron emission tomography for the detection of colorectal adenomas. Dig Liver Dis 2010; 42: 185-90.
11. Chen YK, Kao CH, Liao AC, Shen YY, Su CT. Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan. Anticancer Res 2003; 23: 4357-61.
12. Pandit-Taskar N, Schoder H, Gonen M, Larson SM, Yeung HW. Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET. AJR Am J Roentgenol 2004; 183: 1143-7.
13. Even-Sapir E, Lerman H, Gutman M et al. The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging 2006; 33: 541-52.
14. Israel O, Yefremov N, Bar-Shalom R et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 2005; 46: 758-62.
15. Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005; 46: 752-7.
16. Yasuda S, Fujii H, Nakahara T et al. 18F-FDG PET detection of colonic adenomas. J Nucl Med 2001; 42: 989-92.
17. van Kouwen MC, Nagengast FM, Jansen JB, Oyen WJ, Drenth JP. 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol 2005; 23: 3713-7.
18. Mainenti PP, Salvatore B, D'Antonio D et al. PET/CT colonography in patients with colorectal polyps: a feasibility study. Eur J Nucl Med Mol Imaging 2007; 34: 1594-603.
19. Lee JC, Hartnett GF, Hughes BG, Ravi Kumar AS. The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT. Nucl Med Commun 2009; 30: 333-7.
20. Abouzied MM, Crawford ES, Nabi HA. 18F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol 2005; 33: 145-55; quiz 62-3.
21. Kim S, Chung JK, Kim BT et al. Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET. Clin Positron Imaging 1999; 2: 273-9.
22. Metser U, Even-Sapir E. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Semin Nucl Med 2007; 37: 206-22.